Quantcast

Maryland State Wire

Thursday, November 21, 2024

Maryland: Biologics companies were the least FDA inspected companies in Maryland in Q2 2023

Webp 1nnkuwui7bygddwf9isz0oba9c4q

James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website

James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website

In the second quarter of 2023, three Biologics companies received three FDA inspections in Maryland, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in Maryland, equalling 6.8% of all inspections in the second quarter of 2023.

Of all the Maryland companies involved in the Biologics sector, Wayne Farnsworth, M.D. received the most citations from the FDA in the second quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in Maryland During Q2 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring101--
Compliance: Devices--1--
Food Composition, Standards, Labeling and Econ71--
Foodborne Biological Hazards226--
Monitoring of Marketed Animal Drugs, Feed, and Devices111
Technical Assistance: Food and Cosmetics21--

MORE NEWS